CARFILZOMIB vs KYPROLIS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Attribute	CARFILZOMIB	KYPROLIS
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CARFILZOMIB	CARFILZOMIB
Manufacturer	Hainan Poly Pharm. Co., Ltd.	Onyx Pharms Amgen
Dosage forms	Powder	Injectable
Drug class	Proteasome Inhibitor	Proteasome Inhibitor
Boxed warning	None	None
Treats	Multiple Myeloma	Multiple Myeloma

carfilzomib kyprolis

Rating

New

Pharmacy pays

—

Type

Active ingredient

CARFILZOMIB

Manufacturer

Hainan Poly Pharm. Co., Ltd.

Onyx Pharms Amgen

Dosage forms

Powder

Injectable

Drug class

Proteasome Inhibitor

Boxed warning

None

Treats

Multiple Myeloma

Frequently asked questions

What is the difference between Carfilzomib and Kyprolis?

Both Carfilzomib and Kyprolis share the active ingredient Carfilzomib.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.